SCHEMBL18216975

SCHEMBL18216975

Cc1ccc2nc3ccc(=N)cc-3oc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.50
KDM4E B2RXH2 5/20 0.49
MAPT P10636 3/20 0.49
APP P05067 10/20 0.46
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
TP53 P04637 2/20 0.46
PKM P14618 1/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 2/20 0.43
USP2 O75604 1/20 0.40
MAPK10 P53779 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1093966 0.81 APP (0.68) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL3363350 0.81 RAB9A (0.47) KDM4EMAPTAPPNPC1RAB9A
SCHEMBL12203258 0.81 APP (0.68) APPCYP1A2
SCHEMBL21924480 0.81 APP (0.43) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL15488843 0.80 HSD17B10 (0.49) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL14338730 0.77 MEN1 (0.51) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL11955374 0.76 KDM4E (0.47) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL3133417 0.76 APP (0.39) HSD17B10KDM4EMAPTAPPNPC1
SCHEMBL5541680 0.74 KDM4E (0.63) HSD17B10KDM4EMAPTNPC1RAB9A
SCHEMBL24133266 0.67 KDM4E (0.59) HSD17B10KDM4EMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160326372-A1 INFRARED-SENSITIVE COLOR DEVELOPING COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, PLATE MAKING METHOD FOR LITHOGRAPHIC PRINTING PLATE, AND INFRARED-SENSITIVE COLOR DEVELOPER FUJIFILM CORPORATION (JP) 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326372-A1 INFRARED-SENSITIVE COLOR DEVELOPING COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, PLATE MAKING METHOD FOR LITHOGRAPHIC PRINTING PLATE, AND INFRARED-SENSITIVE COLOR DEVELOPER LAS1L, MAP1LC3A, MAP1LC3C HSD17B10 1188/4885KDM4E 3622/4885MAPT 1376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.